Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 8, 13 November 2023
Open
Access | Article
Progress in the study of the anti-non-small cell lung cancer effects of alkaloid actives
* Author to whom correspondence should be addressed.
Abstract
Non-small cell lung cancer (NSCLC) is a highly lethal type of lung cancer and the current therapeutic challenges remain daunting. Alkaloids have become a compelling area of research due to their diverse structures and wide range of biological activities and are considered as potential antitumor agents. In this paper, we review the research progress of different classes of representative alkaloidal actives in recent years in terms of their anti NSCLC effects, with a view to provide a reference for alkaloidal actives in anti NSCLC research.
Keywords
Non-Small Cell Lung Cancer (NSCLC), Alkaloids, Natural Product Active Substances, Anti-Tumor
References
1. International Agency for Research on Cancer. GLOBOCAN 2020: Lung Cancer. In: Stewart BW, Wild CP, Albain KS (Editors). World Cancer Report: Cancer Research for Cancer Prevention. 16th edition. Lyon, France: International Agency for Research on Cancer; 2021.
2. Pao W, Girard N. New driver mutations in non-small-cell lung cancer. Lancet Oncol. 2011 Feb;12(2):175-180.
3. IARC. Tobacco smoke and involuntary smoking. International Agency for Research on Cancer. 2018.
4. Galeone, C., Pelucchi, C., & La Vecchia, C. Indoor air pollution from household use of solid fuels and risk of cancers other than lung cancer. Environmental Health Perspectives. 2008;116(4):535-540.
5. Howington JA, Blum MG, Chang AC. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. College of Chest Physicians evidence-based clinical practice guidelines. chest. 2013;143(5_suppl):e278S-e313S.
6. Chen H, Lu C. Traditional Chinese medicine for lung cancer. Evid Based Complement Alternat Med. 2017;2017:3705615.
7. Li CQ, Wang G, Li Y. Anti-tumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway. Drug Discov Ther. 2019;13(6):297 -304.
8. Zhou Ailing, Wang Duanheng, Yue Xiaolei, et al. Progress of anti-tumor effects of Chinese medicinal polysaccharides[J]. Chinese Journal of Experimental Formulas, 2022, 28(16): 236-246.
9. MONDAL A, GANDHI A, FIMOGNARI C, et al. Alkaloids for cancer prevention and therapy: current progress and future perspectives[J]. Eur J Pharmacol, 2019, doi: 10. 1016/j.ejphar. 2019. 172472.
10. BHAMBHANI S, KONDHARE K R, GIRI A P. Diversity in chemical structures and biological properties of plant alkaloids[J]. Molecules, 2021, doi: 10. 3390/molecules26113374.
11. WANG Hong, LIU Yue, YANG Liangyu, et al. Progress in the study of antiviral activity of alkaloids and its mechanism[J]. Chinese herbal medicine, 2022, 53(9): 2839-2850.
12. Xie YJ, Gao WN, Wu QB, Yao XJ, Jiang ZB, Wang YW, Wang WJ, Li W, Hussain S, Liu L, Leung EL, Fan XX. Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR AMPK pathway. Pharmacol Res. 2020 Sep;159:104934. doi: 10.1016/j.phrs.2020. 104934. epub 2020 May 25. pmid: 32464330.
13. Hua P, Sun M, Zhang G, Zhang Y, Tian X, Li X, Cui R, Zhang X. Cepharanthine induces apoptosis through reactive oxygen species and mitochondrial dysfunction in human non-small-cell lung cancer cells. Biochem Biophys Res Commun. 2015 May 1;460(2):136-42. doi: 10.1016/j.bbrc.2015.02.131. epub 2015 Mar 5. PMID: 25747710.
14. Sun Y, Wu P, Sun Y, Sharopov FS, Yang Q, Chen F, Wang P, Liang Z. Lycorine possesses notable anticancer potentials in on-small cell lung carcinoma cells via blocking Wnt/β-catenin signaling and epithelial-mesenchymal transition (EMT). Biochem Biophys Res Commun. 2018 Jan 1;495(1):911-921. doi: 10.1016/j.bbrc.2017.11.032. Epub 2017 Nov 7. PMID: 29127013.
15. Kim YR, Han AR, Kim JB, Jung CH. Dendrobine Inhibits γ-Irradiation-Induced Cancer Cell Migration, Invasion and Metastasis in Non-Small Cell Lung Cancer Cells. Biomedicines. 2021 Aug 3;9(8):954. doi: 10.3390/biomedicines9080954. PMID: 34440158; PMCID: PMC8392411.
16. Zhuang Z, Chen Q, Zhong X, Chen H, Yu R, Tang Y. Ginsenoside Rg3, a promising agent for NSCLC patients in the pandemic: a large-scale data mining and systemic biological analysis. J Ginseng Res. 2023 Mar;47(2):291-301. doi: 10.1016/j.jgr.2022.09.006. Epub 2022 Oct 12. PMID: 36249948; PMCID. PMC9553969.
17. Wu S, Chen W, Liu K, Ren F, Zheng D, Xu F, Wu H. Saikosaponin D inhibits proliferation and induces apoptosis of nonsmall cell lung cancer cells by inhibiting the STAT3 pathway. J Int Med Res. 2020 Sep;48(9):300060520937163. doi: 10.1177/0300060520937163. PMID: 32962498; PMCID: PMC7780581.
18. Hou GuoQing. Research on anti-tumor effect and molecular mechanism of corynoxine in human non-small cell lung cancer [D]. Science and Technology, 2020.DOI:10.27157/d.cnki.ghzku.2020.005717.
19. Martino E, Casamassima G, Castiglione S, Cellupica E, Pantalone S, Papagni F, Rui M, Siciliano AM, Collina S. Vinca alkaloids and analogues as anti cancer agents: looking back, peering ahead. Bioorg Med Chem Lett. 2018 Sep 15;28(17):28162826. doi: 10.1016/j.bmcl.2018.06.044. Epub 2018 Jun 25. PMID: 30122223.
20. Alnuqaydan AM, Almutary AG, Azam M, et al. Evaluation of the Cytotoxic Activity and Anti-Migratory Effect of Berberine-Phytantriol Liquid Crystalline Nanoparticle Formulation on Non-Small-Cell Lung Cancer In Vitro. Pharmaceutics. 2022;14(6):1119. doi: 10.3390/ Pharmaceutics14061119. pmid: 35240907.
21. Wall ME, Wani MC, Cook CE, Palmer KH, McPhail AT, Sim GA. Plant antitumor agents. i. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc. 1966;88(16):3888-3890. pmid: 5950653.
22. Liu X, Zou H, Zhao Y, Chen H, Liu T, Wu Z, Yang C, Li Q, Li Y. Tanshinone Inhibits NSCLC by Downregulating AURKA Through Let-7a-5p. Front Genet. 2020 Aug 7. 11:838. doi: 10.3389/fgene.2020.00838. PMID: 32849824; PMCID: PMC7427477.
23. Luo D, Dai X, Tian H, Fan C, Xie H, Chen N, Wang J, Huang L, Wang H, Wang G, Zhang Y. Sophflarine A, a novel matrine-derived alkaloid from Sophora flavescens with therapeutic potential for non-small cell lung cancer through ROSmediated pyroptosis and autophagy. Phytomedicine. 2023 Jul 25;116. 154909. doi: 10.1016/j.phymed.2023.154909. Epub 2023 May 29. PMID: 37269775.
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Modern Medicine and Global Health
- ISBN (Print)
- 978-1-83558-111-7
- ISBN (Online)
- 978-1-83558-112-4
- Published Date
- 13 November 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/8/20240352
- Copyright
- 13 November 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited